National Institutes of Health

Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria – A Model for Mosquito-Borne Diseases

RFA-AI-28-024GrantGrantGrants.gov

Quick Facts

Set-Aside

Full & Open

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support basic research, discovery, and/or preclinical development of highly efficacious vaccines for malaria and potentially other mosquito-borne illness. The program will encourage novel approaches to vaccine design that capitalize on recent technological innovations including structure-based immunogen design, and/or combination vaccines to reduce parasite infection and/or reduce malaria disease burden. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Details

Type: Grant
Deadline: See listing
Source: Grants.gov
First Seen: Apr 9, 2026

Point of Contact

Malaria and Other Mosquito Borne Diseases

[email protected]Please contact via e-mail.

View on Grants.gov

Do More with Drexault

Score My Fit
Draft Proposal with AI

Market Intelligence

Similar Active Opportunities

If you're interested in this contract, you may also want to bid on these.

National Institutes of Health

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Grant

Scientific ResearchR&DData Analytics

National Institutes of Health

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Grant

Scientific ResearchR&DHealthcare

National Institutes of Health

Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)

Grant

R&DHealthcareScientific Research

National Institutes of Health

Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Grant

Scientific ResearchR&DHealthcare

National Institutes of Health

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

Grant

Scientific ResearchHealthcareR&D

National Institutes of Health

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Grant

R&DScientific ResearchHealthcare

Past Similar Contracts

Similar contracts that have recently closed — useful for research and frequency analysis.

NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)

National Institutes of Health

→

Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

National Institutes of Health

→

New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)

National Institutes of Health

→

Single Source: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Required)

National Institutes of Health

→

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)

National Institutes of Health

→

Similar contracts are posted regularly. Set up alerts to get notified when matching contracts appear.

Get alerts for contracts like this →

Browse Contracts

Learn

FAQ

Free Tools

Solutions

Company

Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria – A Model for Mosquito-Borne Diseases

Quick Facts

Description

Details

Point of Contact

Do More with Drexault

Market Intelligence

Similar Active Opportunities

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)

Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Past Similar Contracts

Browse Related

Popular NAICS

Set-Asides

By State

Free Tools

Compare Platforms

Resources

Similar Active Opportunities

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)

Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Past Similar Contracts